Live from the NIH registry
Studies recruiting near Santa Rosa right now
Top 25 of 143 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
Persistent Corneal Epithelial Defect
Phase 2
Interventional 84 participants sought
Glaukos Investigative Site — Petaluma, California (15.2 mi)
· Sponsor: Glaukos Corporation
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Santa Rosa, California (0.6 mi)
· Sponsor: AstraZeneca
Tracking Results of Ablations to Combat AF Registry Generation 2
Atrial Fibrillation
N/A
Observational 10,000 participants sought
Adventist Heart Institute (St. Helena Hospital) — St. Helena, California (13.4 mi)
· Sponsor: AtriCure, Inc.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Providence Medical Foundation ( Site 9543) — Santa Rosa, California (0.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
North Bay Eye Associates /ID# 277071 — Petaluma, California (15.2 mi)
· Sponsor: AbbVie
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Napa, California (25.0 mi)
· Sponsor: Medtronic
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Atherosclerosis
Phase 2
Interventional 162 participants sought
NorthBay Clinical Research — Santa Rosa, California (0.6 mi)
· Sponsor: Genentech, Inc.
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 3
Interventional 364 participants sought
Sutter Pacific Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Urothelial Cancer
Phase 2, Phase 3
Interventional 470 participants sought
Sutter Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Bristol-Myers Squibb
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Advanced or Metastatic Non-small Cell Lung Cancer
Phase 1, Phase 2
Interventional 152 participants sought
Research Site — Santa Rosa, California (0.6 mi)
· Sponsor: AstraZeneca
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
NorthBay Clinical Research, LLC — Santa Rosa, California (0.6 mi)
· Sponsor: Boehringer Ingelheim
Mental Health in Veterans and Families After Group Therapies
Post-Traumatic Stress Disorders
EARLY/Phase 1
Interventional 100 participants sought
Soul Medicine Institute — Santa Rosa, California (0.6 mi)
· Sponsor: Soul Medicine Institute
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: SWOG Cancer Research Network
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Adjustment Disorder
Phase 2
Interventional 100 participants sought
Providence Medical Foundation — Santa Rosa, California (0.6 mi)
· Sponsor: Reunion Neuroscience Inc
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Cardiotoxicity, HER2/Neu Positive
Phase 3
Interventional 491 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: SWOG Cancer Research Network
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Wake Forest University Health Sciences
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Saint Helena Hospital — St. Helena, California (13.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Providence Medical Foundation - Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia
Phase 3
Interventional 303 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain
Lumbar Spinal Stenosis
N/A
Interventional 100 participants sought
Evolve Restorative Center — Santa Rosa, California (0.6 mi)
· Sponsor: Pacific Research Institute
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,260 participants sought
Kaiser Permanente-Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Prostate Cancer, Metastatic Castration Resistant Prostate Cancer
Phase 1
Interventional 174 participants sought
Providence Medical Group Oncology Santa Rosa — Santa Rosa, California (0.6 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
NorthBay Clinical Research- Site Number : 8400066 — Santa Rosa, California (0.6 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company